NCNA is NuCana plc (Healthcare) — a non-dividend-paying stock. Trading at $1.43. Market cap: $6M.
Stock snapshot
| Price | $1.43 |
| Market cap | $6M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About NCNA
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
Related non-dividend companies
Other non-dividend stocks investors research alongside NCNA. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is NCNA's current stock price?
NCNA (NuCana plc) is currently trading at $1.43.
Does NCNA pay a dividend?
NCNA (NuCana plc) does not currently pay a regular dividend.
Track NCNA in DiviDrip
Add NCNA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search NCNA and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.